title: Paradoxical effect of supplementary progesterone between Day 3 and Day 7 on corpus luteum function and conceptus development in cattle.
abstract: The aim of the present study was to investigate the effect of short-term progesterone (P4) supplementation during the early metoestrous period on circulating P4 concentrations and conceptus development in cattle. The oestrous cycles of cross-bred beef heifers were synchronised using a 7-day P4-releasing intravaginal device (PRID® Delta; 1.55 g P4) treatment with administration of a prostaglandin F(2α) analogue (Enzaprost; CEVA Sante Animale) the day before PRID® Delta removal. Only those heifers recorded in standing oestrus (Day 0) were used. In Experiment 1, heifers were randomly assigned to one of five groups: (1) control: no treatment; (2) placebo: insertion of a blank device (no P4) from Day 3 to Day 7; (3) insertion of a PRID® Delta from Day 3 to Day 7; (4) insertion of a PRID® Delta from Day 3 to Day 5; or (5) insertion of a PRID® Delta from Day 5 to Day 7. In vitro-produced blastocysts were transferred to each heifer in Groups 2-5 on Day 7 (n=10 blastocysts per heifer) and conceptuses were recovered when heifers were killed on Day 14. Based on the outcome of Experiment 1, in Experiment 2 heifers were artificially inseminated at oestrus and randomly assigned to one of three treatment groups: (1) placebo; (2) PRID from Day 3 to Day 5; or (3) PRID from Day 3 to Day 7. All heifers were killed on Day 16 and recovered conceptuses were incubated in synthetic oviducal fluid medium for 24 h; spent media and uterine flushes were analysed for interferon-τ (IFNT). In both experiments, daily blood samples were taken to determined serum P4 concentrations. Data were analysed using the PROC MIXED procedure of SAS (SAS Institute, Cary, NC, USA). Insertion of a PRID resulted in an increase (P<0.05) in serum P4 that declined following removal. In Experiment 1, P4 supplementation from Day 3 to Day 5 (17.0±1.4 mm) or Day 3 to Day 7 (11.3±2.3 mm) increased conceptus length compared with placebo (2.1±1.8 mm). Serum P4 was significantly lower from Day 9 to Day 14 (P<0.05) and the weight of the Day 14 corpus luteum (CL) was lower in the PRID Day 3-7 group than the placebo or control groups. In Experiment 2, supplementation from Day 3 to Day 5 (94.0±18.8 mm) or Day 3 to Day 7 (143.6±20.6 mm) increased conceptus length on Day 16 compared with placebo (50.3±17.4 mm). Serum P4 was significantly lower in the two supplemented groups following PRID removal compared with placebo (P<0.05) and was associated with a lower CL weight in the Day 3-7 group. Conceptus length was strongly correlated with the IFNT concentration in the uterine flush (r=0.58; P=0.011) and spent culture medium (r=0.68; P<0.002). The findings of the present study highlight the somewhat paradoxical effects of P4 supplementation when given in the early metoestrous period in terms of its positive effect on conceptus development and its potentially negative effects on CL lifespan.
authors: School of Agriculture and Food Science, University College Dublin, Belfield, Dublin 4, Ireland.
authors: L
authors: L
authors: O'Hara
authors: School of Agriculture and Food Science, University College Dublin, Belfield, Dublin 4, Ireland.
authors: N
authors: N
authors: Forde
authors: School of Agriculture and Food Science, University College Dublin, Belfield, Dublin 4, Ireland.
authors: F
authors: F
authors: Carter
authors: Departamento de Reproducción Animal, Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria, Madrid, Spain.
authors: D
authors: D
authors: Rizos
authors: Departamento de Reproducción Animal, Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria, Madrid, Spain.
authors: V
authors: V
authors: Maillo
authors: Department of Animal Sciences, University of Florida, PO Box 110910, Gainesville, FL 32611-0910, USA.
authors: A D
authors: AD
authors: Ealy
authors: School of Agriculture and Food Science, University College Dublin, Belfield, Dublin 4, Ireland.
authors: A K
authors: AK
authors: Kelly
authors: CEVA Sante Animale, 10 Avenue de la Ballastière 33500 Libourne, France.
authors: P
authors: P
authors: Rodriguez
authors: CEVA Sante Animale, 10 Avenue de la Ballastière 33500 Libourne, France.
authors: N
authors: N
authors: Isaka
authors: School of Agriculture and Food Science, University College Dublin, Belfield, Dublin 4, Ireland.
authors: A C O
authors: AC
authors: Evans
authors: School of Agriculture and Food Science, University College Dublin, Belfield, Dublin 4, Ireland.
authors: P
authors: P
authors: Lonergan
mesh_terms: D000282:Administration, Intravaginal; D000818:Animals; D001755:Blastocyst / Q000187:drug effects / Q000502:physiology; D002417:Cattle; D003338:Corpus Luteum / Q000187:drug effects* / Q000502:physiology; D004334:Drug Administration Schedule; D046149:Embryo Culture Techniques / Q000662:veterinary; D010064:Embryo Implantation / Q000187:drug effects*; D004624:Embryo Transfer / Q000662:veterinary; D047108:Embryonic Development / Q000187:drug effects; D030762:Estrous Cycle / Q000187:drug effects / Q000502:physiology; D005260:Female; D005298:Fertility / Q000187:drug effects*; D005300:Fertility Agents, Female / Q000008:administration & dosage* / Q000097:blood; D005307:Fertilization in Vitro / Q000662:veterinary; D007315:Insemination, Artificial / Q000662:veterinary; D011247:Pregnancy; D011374:Progesterone / Q000008:administration & dosage* / Q000097:blood; D027724:Reproductive Techniques, Assisted / Q000662:veterinary*; D013997:Time Factors
chemical_list: D005300:Fertility Agents, Female; D011374:Progesterone